Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127163261 | 12716326 | 1 | I | 20160830 | 20160906 | 20160906 | EXP | CN-MLMSERVICE-20160831-0404201-2 | CN-009507513-1608CHN015558 | MERCK | 40.00 | YR | M | Y | 0.00000 | 20160906 | MD | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127163261 | 12716326 | 1 | PS | IMIPENEM AND CILASTATIN | CILASTATIN SODIUMIMIPENEM | 1 | UNK | U | U | 50587 | INJECTION | ||||||||
| 127163261 | 12716326 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | U | U | 0 | TABLET | |||||||||
| 127163261 | 12716326 | 3 | SS | PREDNISONE. | PREDNISONE | 1 | U | U | 0 | TABLET | |||||||||
| 127163261 | 12716326 | 4 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | U | U | 0 | |||||||||
| 127163261 | 12716326 | 5 | SS | VANCOMYCIN | VANCOMYCIN | 1 | U | U | 0 | ||||||||||
| 127163261 | 12716326 | 6 | SS | TIGECYCLINE. | TIGECYCLINE | 1 | Oral | 200 MG FOR FIRST DOSE, THEN 100 MG EVERY 12 HOURS | U | U | 0 | 200 | MG | ||||||
| 127163261 | 12716326 | 7 | SS | TIGECYCLINE. | TIGECYCLINE | 1 | Oral | 100 MG, Q12H | U | U | 0 | 100 | MG | Q12H | |||||
| 127163261 | 12716326 | 8 | SS | FOSFOMYCIN | FOSFOMYCIN | 1 | UNK | U | U | 0 | |||||||||
| 127163261 | 12716326 | 9 | SS | MOXIFLOXACIN. | MOXIFLOXACIN | 1 | Intravenous (not otherwise specified) | U | U | 0 | |||||||||
| 127163261 | 12716326 | 10 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | U | U | 0 | ||||||||||
| 127163261 | 12716326 | 11 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | U | U | 0 | ||||||||||
| 127163261 | 12716326 | 12 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | U | U | 0 | ||||||||||
| 127163261 | 12716326 | 13 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | U | U | 0 | ||||||||||
| 127163261 | 12716326 | 14 | SS | cefoperazone sodium (+) sulbactam sodium | CEFOPERAZONE SODIUMSULBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | U | U | 0 | |||||||||
| 127163261 | 12716326 | 15 | SS | EPIRUBICIN | EPIRUBICIN | 1 | U | U | 0 | ||||||||||
| 127163261 | 12716326 | 16 | SS | EPIRUBICIN | EPIRUBICIN | 1 | U | U | 0 | ||||||||||
| 127163261 | 12716326 | 17 | C | VORICONAZOLE. | VORICONAZOLE | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 127163261 | 12716326 | 18 | C | gemcitabine (+) oxaliplatin | 2 | 0 | |||||||||||||
| 127163261 | 12716326 | 19 | C | PEGASPARGASE | PEGASPARGASE | 1 | 0 | ||||||||||||
| 127163261 | 12716326 | 20 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | TABLET | |||||||||||
| 127163261 | 12716326 | 21 | C | IFOSFAMIDE. | IFOSFAMIDE | 1 | 0 | ||||||||||||
| 127163261 | 12716326 | 22 | C | ETOPOSIDE. | ETOPOSIDE | 1 | 0 | ||||||||||||
| 127163261 | 12716326 | 23 | C | GLOBULIN, IMMUNE | HUMAN IMMUNOGLOBULIN G | 1 | 0 | ||||||||||||
| 127163261 | 12716326 | 24 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 0 | INJECTION | |||||||||||
| 127163261 | 12716326 | 25 | C | MITOXANTRONE HYDROCHLORIDE. | MITOXANTRONE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127163261 | 12716326 | 1 | Pneumonia klebsiella |
| 127163261 | 12716326 | 2 | Lymphoma |
| 127163261 | 12716326 | 3 | Chemotherapy |
| 127163261 | 12716326 | 4 | Infection |
| 127163261 | 12716326 | 5 | Pneumonia klebsiella |
| 127163261 | 12716326 | 6 | Pneumonia klebsiella |
| 127163261 | 12716326 | 8 | Pneumonia klebsiella |
| 127163261 | 12716326 | 9 | Infection |
| 127163261 | 12716326 | 10 | Lymphoma |
| 127163261 | 12716326 | 11 | Chemotherapy |
| 127163261 | 12716326 | 12 | Lymphoma |
| 127163261 | 12716326 | 13 | Chemotherapy |
| 127163261 | 12716326 | 14 | Infection |
| 127163261 | 12716326 | 15 | Lymphoma |
| 127163261 | 12716326 | 16 | Chemotherapy |
| 127163261 | 12716326 | 17 | Infection |
| 127163261 | 12716326 | 18 | Lymphoma |
| 127163261 | 12716326 | 19 | Lymphoma |
| 127163261 | 12716326 | 20 | Lymphoma |
| 127163261 | 12716326 | 21 | Lymphoma |
| 127163261 | 12716326 | 22 | Lymphoma |
| 127163261 | 12716326 | 24 | Lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127163261 | 12716326 | OT |
| 127163261 | 12716326 | LT |
| 127163261 | 12716326 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127163261 | 12716326 | Drug ineffective | |
| 127163261 | 12716326 | Klebsiella infection | |
| 127163261 | 12716326 | Multiple-drug resistance | |
| 127163261 | 12716326 | Pathogen resistance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |